Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$28.51
Last update: Dec 17, 4:00 PM
Comments
Loading...
Ascentage Pharma Group Analyst Ratings and Price Targets | NASDAQ:AAPG | Benzinga
Ascentage Pharma Group International has a consensus price target of $48.5 based on the ratings of 5 analysts. The high is $51 issued by Truist Securities on November 24, 2025. The low is $45 issued by Oppenheimer on December 4, 2025. The 3 most-recent analyst ratings were released by Oppenheimer, Truist Securities, and BTIG on December 4, 2025, November 24, 2025, and November 10, 2025, respectively. With an average price target of $48.67 between Oppenheimer, Truist Securities, and BTIG, there's an implied 70.70% upside for Ascentage Pharma Group International from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
Truist Securities
BTIG
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Ascentage Pharma Group
FAQ
What is the target price for Ascentage Pharma Group (AAPG) stock?
The latest price target for Ascentage Pharma Group (NASDAQ:AAPG) was reported by Oppenheimer on December 4, 2025. The analyst firm set a price target for $45.00 expecting AAPG to rise to within 12 months (a possible 57.84% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ascentage Pharma Group (AAPG)?
The latest analyst rating for Ascentage Pharma Group (NASDAQ:AAPG) was provided by Oppenheimer, and Ascentage Pharma Group initiated their outperform rating.
When was the last upgrade for Ascentage Pharma Group (AAPG)?
There is no last upgrade for Ascentage Pharma Group
When was the last downgrade for Ascentage Pharma Group (AAPG)?
There is no last downgrade for Ascentage Pharma Group.
When is the next analyst rating going to be posted or updated for Ascentage Pharma Group (AAPG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ascentage Pharma Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ascentage Pharma Group was filed on December 4, 2025 so you should expect the next rating to be made available sometime around December 4, 2026.
Is the Analyst Rating Ascentage Pharma Group (AAPG) correct?
While ratings are subjective and will change, the latest Ascentage Pharma Group (AAPG) rating was a initiated with a price target of $0.00 to $45.00. The current price Ascentage Pharma Group (AAPG) is trading at is $28.51, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
